• About
  • Subscribe
  • Advertise
  • Contact
Thursday, December 5, 2024
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Business case put forward for Adelaide’s first public eye hospital

by Myles Hume
September 2, 2020
in Local, News
Reading Time: 3 mins read
A A
Adelaide doesn’t have a standalone public ophthalmic hospital like other Australian capital cities.

Adelaide doesn’t have a standalone public ophthalmic hospital like other Australian capital cities.

Share on FacebookShare on Twitter

Two prominent South Australian ophthalmologists are lobbying their state government to consider an $8 million proposal to develop Adelaide’s first dedicated public eye hospital.

The new outpatient facility would be based in the CBD and replace ophthalmology departments that currently exist within larger general hospitals in Adelaide. It would also become the state’s epicentre for ophthalmology training, clinical trials and a new interdisciplinary vision and eye research centre.

Robert Casson.

The project is being spearheaded by Professor Robert Casson, a consultant ophthalmologist at the Royal Adelaide Hospital and head of the discipline of ophthalmology and visual science at Adelaide University. He is being supported by Australian of the Year and ophthalmologist Dr James Muecke.

Casson told Insight he first proposed the project in 2015, but state government and bureaucratic inertia has limited progress. He recently presented a detailed business case to the government, highlighting the efficiencies that could be generated from a public eye hospital.

“Adelaide doesn’t have a dedicated public ophthalmic hospital like some of the other states in Australia and many other cities around the world,” he said.

“All public ophthalmic services are delivered inside large general hospitals. The cost of cataract surgery in general theatres at the Royal Adelaide Hospital, for example, is significantly greater than what it would cost in a day surgery. We are trying to point out the state government isn’t getting value for money with the current system – they are paying way too much for a service that could be provided at a much lower cost and more efficiently in a dedicated facility.”

Casson said ophthalmology departments that had been “shoehorned” into general public hospitals were not adequately equipped for the high volume and throughput of ophthalmology where a large proportion of procedural work is performed in the outpatient setting.

If adopted, the new eye hospital would become the city’s teaching hospital for registrars and junior doctors and would replace ophthalmology departments with the Royal Adelaide Hospital, The Queen Elizabeth Hospital in the city’s northeast and possibly Modbury Hospital in the northwest. They would, in turn, amalgamate into the proposed eye hospital.

James Muecke.

“We’ve identified an excellent site in the CBD in a pre-existing building that is architecturally suitable for day surgery – and our costings suggest that the fit-out for three theatres and the outpatient facilities would be about $8 million,” Casson said.

“We aren’t envisaging inpatients here, they would remain at the Royal Adelaide, but we are planning on optometrists working alongside ophthalmologists. We are also planning multi-disciplinary clinics, so the aim is to be optimising the patient care in an efficient way with multi-disciplinary teams to reduce waiting times.”

New research centre 

Casson said the eye hospital would also become the epicentre for clinical eye research and trials in the state.

Another unique component is a yet-to-be established Centre for Interdisciplinary Vision and Eye Research (CIVER), which would bring together a number of research areas in South Australia that could help improve eye healthcare.

“Examples of that are laser technology, the new Australian Institute for Machine Learning (University of Adelaide), which ophthalmology and optometry lend itself to beautifully with our imaged based data,” Casson said.

“In South Australia, we also have the Centre for Nanoscale BioPhotonics, which does some really interesting work. We have already collaborated with them for potentially new imaging technologies to obtain real-time information about retinal metabolism, as an example. Genetics research at Flinders University would also be part of it.”

Casson said the proposal was now with the state government which wants to conduct its own costings.

“Overall, it’s an exciting project and the research component is particularly interesting. If we can achieve this it would be something really great for South Australia,” he said.

Tags: AdelaideAdelide eye hospitalAustralian of the YearCBDCentre for Interdisciplinary Vision and Eye ResearchCIVERclinicfacilityJames Muecke.Modbury Hospitalophthalmologyophthalmology departmentspublic hospitalRobert CassonRoyal Adelaide HospitalSouth AustraliaThe Queen Elizabeth Hospital

Related Posts

A new WA clinic will give Aboriginal communities and others greater access to eyecare. Image: Sawoon/stock.adobe.com

New clinic will help address inequities in Aboriginal eyecare

by Staff Writer
December 5, 2024

A new eye clinic aims to make a significant impact in transforming eyecare for Aboriginal communities in Western Australia. A...

Or lack of it, depending on where you live, is the concern of the CPMC and others. Image: BJP7images/stock.adobe.com.

Health ministers warned that fast-track changes could bring ‘postcode’ health care

by Staff Writer
December 5, 2024

Australia’s state health ministers have been warned that the proposed fast-track registration of Specialist International Medical Graduates (SIMGs) risks exacerbating...

Alcon has confirmed its new Unity systems are now registered in Australia, and will be commercially available in 2025. Image: Konektus Photo/Shutterstock.com.

All-new Alcon Unity vitreoretinal and cataract systems approved in Australia

by Myles Hume
December 4, 2024

Alcon has revealed its “highly anticipated” Unity Vitreoretinal Cataract System and Unity Cataract System have been included on the Australian...

Join our newsletter

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited